Literature DB >> 19843691

Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline.

Øystein Brorson1, Sverre-Henning Brorson, John Scythes, James MacAllister, Andrew Wier, Lynn Margulis.   

Abstract

Persistence of tissue spirochetes of Borrelia burgdorferi as helices and round bodies (RBs) explains many erythema-Lyme disease symptoms. Spirochete RBs (reproductive propagules also called coccoid bodies, globular bodies, spherical bodies, granules, cysts, L-forms, sphaeroplasts, or vesicles) are induced by environmental conditions unfavorable for growth. Viable, they grow, move and reversibly convert into motile helices. Reversible pleiomorphy was recorded in at least six spirochete genera (>12 species). Penicillin solution is one unfavorable condition that induces RBs. This antibiotic that inhibits bacterial cell wall synthesis cures neither the second "Great Imitator" (Lyme borreliosis) nor the first: syphilis. Molecular-microscopic techniques, in principle, can detect in animals (insects, ticks, and mammals, including patients) helices and RBs of live spirochetes. Genome sequences of B. burgdorferi and Treponema pallidum spirochetes show absence of >75% of genes in comparison with their free-living relatives. Irreversible integration of spirochetes at behavioral, metabolic, gene product and genetic levels into animal tissue has been documented. Irreversible integration of spirochetes may severely impair immunological response such that they persist undetected in tissue. We report in vitro inhibition and destruction of B. burgdorferi (helices, RBs = "cysts") by the antibiotic Tigecycline (TG; Wyeth), a glycylcycline protein-synthesis inhibitor (of both 30S and 70S ribosome subunits). Studies of the pleiomorphic life history stages in response to TG of both B. burgdorferi and Treponema pallidum in vivo and in vitro are strongly encouraged.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843691      PMCID: PMC2774030          DOI: 10.1073/pnas.0908236106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  Borrelia genomes in the year 2000.

Authors:  S Casjens
Journal:  J Mol Microbiol Biotechnol       Date:  2000-10

2.  Spirochete and protist symbionts of a termite (Mastotermes electrodominicus) in Miocene amber.

Authors:  Andrew Wier; Michael Dolan; David Grimaldi; Ricardo Guerrero; Jorge Wagensberg; Lynn Margulis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

3.  Serum-starvation-induced changes in protein synthesis and morphology of Borrelia burgdorferi.

Authors:  P S Alban; P W Johnson; D R Nelson
Journal:  Microbiology       Date:  2000-01       Impact factor: 2.777

4.  Spirochaeta perfilievii sp. nov., an oxygen-tolerant, sulfide-oxidizing, sulfur- and thiosulfate-reducing spirochaete isolated from a saline spring.

Authors:  Galina Dubinina; Margarita Grabovich; Natalia Leshcheva; Frederick A Rainey; Ekaterina Gavrish
Journal:  Int J Syst Evol Microbiol       Date:  2010-02-19       Impact factor: 2.747

5.  Conversion of Borrelia garinii cystic forms to motile spirochetes in vivo.

Authors:  I Gruntar; T Malovrh; R Murgia; M Cinco
Journal:  APMIS       Date:  2001-05       Impact factor: 3.205

6.  Cystic forms of Borrelia burgdorferi sensu lato: induction, development, and the role of RpoS.

Authors:  Rossella Murgia; Chiara Piazzetta; Marina Cinco
Journal:  Wien Klin Wochenschr       Date:  2002-07-31       Impact factor: 1.704

7.  In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi.

Authors:  P Kraiczy; J Weigand; T A Wichelhaus; P Heisig; H Backes; V Schäfer; G Acker; V Brade; K P Hunfeld
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

8.  Preclinical pharmacology of GAR-936, a novel glycylcycline antibacterial agent.

Authors:  S J Projan
Journal:  Pharmacotherapy       Date:  2000-09       Impact factor: 4.705

9.  An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to tinidazole.

Authors:  Oystein Brorson; Sverre-Henning A Brorson
Journal:  Int Microbiol       Date:  2004-06       Impact factor: 2.479

10.  An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to hydroxychloroquine.

Authors:  O Brorson; S H Brorson
Journal:  Int Microbiol       Date:  2002-03       Impact factor: 2.479

View more
  29 in total

Review 1.  Exit from dormancy in microbial organisms.

Authors:  Jonathan Dworkin; Ishita M Shah
Journal:  Nat Rev Microbiol       Date:  2010-10-25       Impact factor: 60.633

2.  HtrA, a Temperature- and Stationary Phase-Activated Protease Involved in Maturation of a Key Microbial Virulence Determinant, Facilitates Borrelia burgdorferi Infection in Mammalian Hosts.

Authors:  Meiping Ye; Kavita Sharma; Meghna Thakur; Alexis A Smith; Ozlem Buyuktanir; Xuwu Xiang; Xiuli Yang; Kamoltip Promnares; Yongliang Lou; X Frank Yang; Utpal Pal
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

Review 3.  A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease.

Authors:  Paul M Lantos; Paul G Auwaerter; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

4.  Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability.

Authors:  Radha Iyer; Priyanka Mukherjee; Kemeng Wang; Joshua Simons; Gary P Wormser; Ira Schwartz
Journal:  J Clin Microbiol       Date:  2012-12-26       Impact factor: 5.948

Review 5.  Lyme Disease Frontiers: Reconciling Borrelia Biology and Clinical Conundrums.

Authors:  Vladimir V Bamm; Jordan T Ko; Iain L Mainprize; Victoria P Sanderson; Melanie K B Wills
Journal:  Pathogens       Date:  2019-12-16

6.  Formation and characterization of non-growth states in Clostridium thermocellum: spores and L-forms.

Authors:  Elizabeth B Mearls; Javier A Izquierdo; Lee R Lynd
Journal:  BMC Microbiol       Date:  2012-08-16       Impact factor: 3.605

7.  Lyme disease: the next decade.

Authors:  Raphael B Stricker; Lorraine Johnson
Journal:  Infect Drug Resist       Date:  2011-01-07       Impact factor: 4.003

8.  Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi.

Authors:  Eva Sapi; Navroop Kaur; Samuel Anyanwu; David F Luecke; Akshita Datar; Seema Patel; Michael Rossi; Raphael B Stricker
Journal:  Infect Drug Resist       Date:  2011-05-03       Impact factor: 4.003

9.  Borrelia burgdorferi requires the alternative sigma factor RpoS for dissemination within the vector during tick-to-mammal transmission.

Authors:  Star M Dunham-Ems; Melissa J Caimano; Christian H Eggers; Justin D Radolf
Journal:  PLoS Pathog       Date:  2012-02-16       Impact factor: 6.823

Review 10.  Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatment Lyme Disease Syndromes.

Authors:  Felipe C Cabello; Monica E Embers; Stuart A Newman; Henry P Godfrey
Journal:  mBio       Date:  2022-04-25       Impact factor: 7.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.